Phase I and Pharmacokinetic Study of the Farnesyl Transferase Inhibitor, R115777, in Combination With Topotecan
Latest Information Update: 28 May 2019
At a glance
- Drugs Tipifarnib (Primary) ; Topotecan (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 11 Jan 2007 Status changed from recruiting to completed
- 24 Aug 2005 New trial record.